Noho Labs
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Noho Labs - overview
Location
San Francisco, CA, US
Primary Industry
Biotechnology
About
Noho Labs is a U. S. -based company specializing in concierge wellness services, providing personalized health optimization through advanced peptide protocols tailored for individual health needs. Founded in San Francisco, Noho Labs focuses on personalized health solutions utilizing peptide technology.
The firm has undergone a strategic shift towards concierge wellness services, enhancing its offerings to clients. The company has successfully completed 2 deals and has raised pre-seed funding co-led by 8VC and Verified Capital, with the total amount undisclosed. Noho Labs offers a concierge wellness service centered on personalized health optimization through precision peptide protocols. Their core products are tailored peptide compounds that enhance energy, immune function, emotional balance, sleep quality, longevity, and skin integrity.
Each protocol is customized to align with individual biological profiles and health goals, serving health-conscious consumers across the United States who prioritize evidence-based wellness solutions. Noho Labs generates revenue through a subscription-based model for its wellness services, providing clients with access to personalized peptide protocols and clinical support. Clients start by completing an intake form that guides the design of their unique regimen. The firm utilizes a direct-to-consumer structure, with a dedicated clinical team managing the delivery of peptide products and continuous consultation.
Pricing plans reflect the premium nature of their personalized offerings. Noho Labs aims to launch new advanced peptide products tailored for specific health outcomes within the coming year. The company is targeting expansion into additional U. S.
regions to reach a broader audience of health-conscious consumers. Recent funding will be allocated to enhance product development and market penetration efforts, supporting the company’s growth strategy following their pre-seed funding round.
Current Investors
8VC, Verified Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.noholabs.com
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.